McGann Joseph P, Bahuva Ronak
Emergency Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.
Internal Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.
Cureus. 2021 Oct 30;13(10):e19147. doi: 10.7759/cureus.19147. eCollection 2021 Oct.
Guillain-Barré syndrome (GBS) is a rare neurologic disorder in which the host immune system damages peripheral nerve cells. Although classically described as an ascending paralysis, GBS can present in a myriad of ways. As peripheral nerve conduction becomes impaired, symptoms can range from mild weakness to a life-threatening paralysis of the respiratory muscles. Patients frequently experience prolonged recovery times, with residual effects often lasting up to a year or longer. The exact cause of the disorder is not fully understood, but its development most often follows infection with numerous different pathogens. Most recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been identified as a possible cause. We present the case of a 63-year-old male presenting with signs and symptoms consistent with GBS who was later identified to have recently been infected with the SARS-CoV-2. Our report adds to the growing number of GBS cases that have been associated with SARS-CoV-2 and prompts further consideration of the potential sequelae of COVID-19.
吉兰-巴雷综合征(GBS)是一种罕见的神经系统疾病,其中宿主免疫系统会损害周围神经细胞。尽管经典描述为上行性麻痹,但GBS可以有多种表现形式。随着周围神经传导受损,症状范围可从轻度无力到危及生命的呼吸肌麻痹。患者常常经历较长的恢复时间,残留影响通常可持续长达一年或更长时间。该疾病的确切病因尚未完全明确,但其发病最常继发于多种不同病原体的感染。最近,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染已被确定为一种可能的病因。我们报告了一例63岁男性,其出现了与GBS一致的体征和症状,后来被确定近期感染了SARS-CoV-2。我们的报告增加了与SARS-CoV-2相关的GBS病例数量,并促使人们进一步考虑COVID-19的潜在后遗症。